In this study, the presence of EZH2 mutations was of particular interest because it was higher in the GC-DLBCL subtype, which may suggest that the search for these mutations could help identify patients with a worse prognosis within the GC subtype. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.